US Stock MarketDetailed Quotes
ITCI Intra-Cellular Therapies
- 78.340
- -0.340-0.43%
Close Oct 18 16:00 ET
- 78.340
- 0.0000.00%
Post 20:01 ET
8.28BMarket Cap-91093P/E (TTM)
79.455High78.035Low505.84KVolume78.220Open78.680Pre Close39.69MTurnover0.49%Turnover RatioLossP/E (Static)105.67MShares84.89052wk High7.23P/B8.10BFloat Cap45.50052wk Low--Dividend TTM103.39MShs Float84.890Historical High--Div YieldTTM1.81%Amplitude6.750Historical Low78.470Avg Price1Lot Size
Intra-Cellular Therapies Key Stats
EPS
According to the latest financial report of Intra-Cellular Therapies, the latest earnings per share (TTM) for the company is -0.16. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Intra-Cellular Therapies's free cash flow? The latest report shows it as 489.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Intra-Cellular Therapies shows that the company's current ratio is 7.81, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Intra-Cellular Therapies, the quick ratio is 7.22, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Intra-Cellular Therapies? The latest ROE figure is -1.86%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Intra-Cellular Therapies, the total asset return on investment (ROA) is -1.57%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Intra-Cellular Therapies's latest financial report to see how their gross margin is doing - currently at 92.96%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Intra-Cellular Therapies, the net profit margin is -10.05%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data